Research News: Oral therapy

Posted by GIModerator @gimoderator, Nov 5, 2014

The results of a recent phase II study evaluating 160 patients with active Crohn’s disease, with a high dose of mongersen were recently published. The study demonstrated a statistically significant remission rate of 65% compared to 9.5% for a placebo, measured after two weeks of treatment. Learn more here:

Interested in more discussions like this? Go to the National Crohn's/Ulcerative Colitis Support Group group.

Has anyone been on a clinical trial evaluating mongersen? Share your experience!

Please sign in or register to post a reply.